+5 more ↓
78%
Finnrick rating
#1 of 108 BPC-157 vendors
18 of 21 classifiable tests passed
natural 86% · customers 4.6★ (11)
methodology · Purity focus
Finnrick analysis · BPC-157

Three purity misses hold back HK Peptides' BPC-157, including 98.4% purity in January; fill was sometimes high, up to +27%. Later tests rebounded to 99.6–99.9% purity, but batch-ID gaps sit outside this purity-focused score.

methodology →
vendor intelligence report
Vendor Intelligence Report: HK Peptides

Corporate records and homepage evidence point past the Hong Kong branding to a mainland operating trail and a separate manufacturing-facing domain with verification friction. The report maps the HKMS PEP/HPT adjacency, copycat domains, crypto payment rails, and forum impersonation signals.

26 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.47
87%
125
2
Retatrutide
$1.09
86%
135
3
GHK-Cu
$0.07
85%
48
4
BPC-157selected
$1.36
78%
21
5
PT-141
-
74%
7
6
Melanotan II
$0.41
69%
12
7
Cagrilintide
$2.30
64%
10
8
Semaglutide
$0.70
64%
10
9
Ipamorelin
$0.81
58%
13
10
Sermorelin
$1.57
49%
5
11
TB-500
$1.17
46%
9
12
Tesamorelin
$2.00
46%
33
13
CJC-1295
$1.90
29%
10
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Nov 2025: 66%17 Nov 2025: 63%25 Nov 2025: 66%17 Dec 2025: 69%1 Jan 2026: 65%15 Jan 2026: 62%10 Feb 2026: 64%11 Feb 2026: 67%11 Feb 2026: 69%20 Feb 2026: 71%26 Feb 2026: 73%2 Mar 2026: 74%2 Mar 2026: 76%23 Apr 2026: 77%12 Jun 2026: 78%9 Aug 2026: current 78%66%71%78%Nov 25Aug 26
Showing BPC-157 tests only
HK Peptides BPC-157 test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
12 Jun 2026Pass
Tested
lab nameView COA
23 Apr 2026Pass
Tested
lab nameView COA
2 Mar 2026Pass
Tested
lab nameView COA
2 Mar 2026Pass
Tested
lab nameView COA
26 Feb 2026Pass
Tested
lab nameView COA
20 Feb 2026Pass
Tested
lab nameView COA
11 Feb 2026Pass
Tested
lab nameView COA
11 Feb 2026Pass
Tested
lab nameView COA
10 Feb 2026Pass
Tested
lab nameView COA
15 Jan 2026Fail
Tested
lab nameView COA
1-10 of 21

About HK Peptides test results from Finnrick

HK Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 13 peptides and 438 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HK Peptides peptides in this dataset are BPC-157 (21 tests) and Melanotan II (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.